Search Results - Daniel C Malone

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Cost-Effectiveness Analysis of a Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder by Fulton F. Velez, Daniel C. Malone

    Published in Journal of Market Access & Health Policy (2021-01-01)
    Get full text
    Article


  2. 2

    Interpretable Machine Learning Prediction of Drug-Induced QT Prolongation: Electronic Health Record Analysis by Steven T Simon, Katy E Trinkley, Daniel C Malone, Michael Aaron Rosenberg

    Published in Journal of Medical Internet Research (2022-12-01)
    Get full text
    Article


  3. 3

    A systematic review of real-world healthcare resource use and costs of Clostridioides difficile infections by Daniel C. Malone, Edward P. Armstrong, Dan Gratie, Sissi V. Pham, Alpesh Amin

    Get full text
    Article


  4. 4

    Patient Experiences with Clostridioides difficile Infection and Its Treatment: A Systematic Literature Review by Edward P. Armstrong, Daniel C. Malone, Duska M. Franic, Sissi V. Pham, Dan Gratie, Alpesh Amin

    Published in Infectious Diseases and Therapy (2023-07-01)
    Get full text
    Article


  5. 5

    Evaluation of Digital Mental Health Technologies in the United States: Systematic Literature Review and Framework Synthesis by Julianna Catania, Steph Beaver, Rakshitha S Kamath, Emma Worthington, Minyi Lu, Hema Gandhi, Heidi C Waters, Daniel C Malone

    Published in JMIR Mental Health (2024-08-01)
    Get full text
    Article


  6. 6

    Alzheimer's disease medication and risk of all‐cause mortality and all‐cause hospitalization: A retrospective cohort study by Sandipan Bhattacharjee, Asad E. Patanwala, Wei‐Hsuan Lo‐Ciganic, Daniel C. Malone, Jeannie K. Lee, Shannon M. Knapp, Terri Warholak, William J. Burke

    Get full text
    Article


  7. 7

    Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients by Daniel C. Malone, Rebecca Dean, Ramesh Arjunji, Ivar Jensen, Phil Cyr, Beckley Miller, Benit Maru, Douglas M. Sproule, Douglas E. Feltner, Omar Dabbous

    Published in Journal of Market Access & Health Policy (2019-01-01)
    Get full text
    Article


  8. 8

    Assessing the value of delandistrogene moxeparvovec (SRP-9001) gene therapy in patients with Duchenne muscular dystrophy in the United States by Alexa C. Klimchak, Lauren E. Sedita, Louise R. Rodino-Klapac, Jerry R. Mendell, Craig M. McDonald, Katherine L. Gooch, Daniel C. Malone

    Published in Journal of Market Access & Health Policy (2023-12-01)
    Get full text
    Article


  9. 9

    Estimating health state utilities in Duchenne muscular dystrophy using the health utilities index and EQ-5D-5L by Ivana F. Audhya, Shelagh M. Szabo, Andrea Bever, Fiona O’Sullivan, Daniel C. Malone, David Feeny, Peter Neumann, Susan T. Iannaccone, P. Jayasinghe, Katherine L. Gooch

    Published in Journal of Patient-Reported Outcomes (2023-12-01)
    Get full text
    Article


  10. 10

    Effectiveness and Efficiency of Non-drug Therapy Among Community-Dwelling Adults With Hypertension in China: A Protocol for Network Meta-Analysis and Cost-Effectiveness Analysis by Taihang Shao, Taihang Shao, Xia Li, Xia Li, Chengchao Zhou, Xiao Zang, Daniel C. Malone, Liang Zhang, Jifang Zhou, Jifang Zhou, Wenxi Tang, Wenxi Tang

    Published in Frontiers in Medicine (2021-02-01)
    Get full text
    Article


  11. 11

    An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and... by Rebecca Dean, Ivar Jensen, Phil Cyr, Beckley Miller, Benit Maru, Douglas M. Sproule, Douglas E. Feltner, Thomas Wiesner, Daniel C. Malone, Matthias Bischof, Walter Toro, Omar Dabbous

    Published in Journal of Market Access & Health Policy (2021-01-01)
    Get full text
    Article


  12. 12

    Shared Decision-Making for Drug-Drug Interactions: Formative Evaluation of an Anticoagulant Drug Interaction by Ainhoa Gomez Lumbreras, Thomas J Reese, Guilherme Del Fiol, Malinda S Tan, Jorie M Butler, Jason T Hurwitz, Mary Brown, Kensaku Kawamoto, Henrik Thiess, Maria Wright, Daniel C Malone

    Published in JMIR Formative Research (2022-10-01)
    Get full text
    Article


  13. 13

    Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C) by Charles E Leonard, Ainhoa Gomez-Lumbreras, Daniel C Malone, Kathleen M Andersen, G Caleb Alexander, Olga V Kravchenko, Richard D Boyce, Paul T Kocis, Lorenzo Villa Zapata, Malinda Tan, Hemalkumar Mehta

    Published in BMJ Open (2022-12-01)
    Get full text
    Article


  14. 14

    Clinician preferences for computerised clinical decision support for medications in primary care: a focus group study by Katy E Trinkley, Weston W Blakeslee, Daniel D Matlock, David P Kao, Amanda G Van Matre, Robert Harrison, Cynthia L Larson, Nic Kostman, Jennifer A Nelson, Chen-Tan Lin, Daniel C Malone

    Published in BMJ Health & Care Informatics (2019-12-01)
    Get full text
    Article


  15. 15

    Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study. by Wei-Hsuan Lo-Ciganic, James L Huang, Hao H Zhang, Jeremy C Weiss, C Kent Kwoh, Julie M Donohue, Adam J Gordon, Gerald Cochran, Daniel C Malone, Courtney C Kuza, Walid F Gellad

    Published in PLoS ONE (2020-01-01)
    Get full text
    Article


  16. 16

    Real-world evidence for coverage determination of treatments for rare diseases by Victoria W. Dayer, Michael F. Drummond, Omar Dabbous, Mondher Toumi, Peter Neumann, Sean Tunis, Nelson Teich, Shadi Saleh, Ulf Persson, Johann-Matthias Graf von der Schulenburg, Daniel C. Malone, Tay Salimullah, Sean D. Sullivan

    Published in Orphanet Journal of Rare Diseases (2024-02-01)
    Get full text
    Article


Search Tools: